← Back to headlines
Higher-Dose Wegovy Shows Significant Weight Loss in Patients
Novo Nordisk has announced that a higher-dose version of its weight-loss drug, Wegovy, helped some patients lose nearly 28% of their body weight. Early responders to the increased dosage showed additional significant weight reduction.
12 May, 11:05 — 12 May, 14:00
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual108d ago
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.
Read full article →seeking-alphaMixed108d ago
Novo says early responders to higher-dose Wegovy lost additional body weight
Read full article →Coverage Timeline
First report: seeking-alpha · 12 May, 11:05|Full coverage: 2 · 3h|Window: 3h
Left-leaningCenterRight-leaning
